Tag: Stem Cells
Advisory Panel Rejects Nearly All Proposals for Fetal Tissue Research
Nearly two-thirds of the members of the panel are outspoken opponents of fetal tissue research
Second Case of HIV-1 Cure After Stem Cell Transplant Reported
HIV-1 viral load remained undetectable in plasma in patient up to 30 months after transplant
Outcomes Steadily Improve for Multiple Myeloma Treated With ASCT
Patients treated in 2014 or later had superior OS, reduced excess risk for multiple myeloma death
Further Improvements in Survival Seen After Allogeneic Transplant
2003 to 2017 saw reduction in nonrelapse mortality, relapse of cancer, relapse-related and overall mortality
Untreated Oral Infection Not Tied to Stem Cell Transplant Outcomes
Untreated oral infections pretransplant not linked to post-HSCT survival during six-month follow-up
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
Many Multiple Sclerosis Patients Considering Stem Cell Transplant
However, many are not well-informed regarding stem cell transplants
Use of Novel Therapy, Stem Cell Transplant in MM Varies by Race
African-Americans, Hispanics have longer time from MM diagnosis to novel therapy initiation than whites
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma
Autologous stem cell transplantation explored for high-risk, early therapy failure FL prior to rituximab use
